Patents by Inventor IRM LLC

IRM LLC has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DUAL FUNCTION PROTEINS FOR TREATING METABOLIC DISORDERS
    Publication number: 20130129724
    Abstract: The present invention relates to the identification of new proteins comprising fibroblast growth factor 21 (FGF21) and other metabolic regulators, including variants thereof, known to improve metabolic profiles in subjects to whom they are administered. Also disclosed are methods for treating FGF21-associated disorders, GLP-1-associated disorders, and Exendin-4-associated disorders, including metabolic conditions.
    Type: Application
    Filed: September 25, 2012
    Publication date: May 23, 2013
    Applicants: IRM LLC, NOVARTIS AG
    Inventors: Novartis AG, IRM LLC
  • COMPOUNDS AND METHODS FOR MODULATING G PROTEIN-COUPLED RECEPTORS
    Publication number: 20130096165
    Abstract: The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with or mediated by G protein-coupled receptors, in particular G protein-coupled receptor 120.
    Type: Application
    Filed: December 4, 2012
    Publication date: April 18, 2013
    Applicant: IRM LLC
    Inventor: IRM LLC